FDAFDA · Food and drugs·Recall number D-0763-2022
SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-130-02
Published April 13, 2022 · Recall initiated: March 21, 2022
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recall details
- Manufacturer
- Adamis Pharmaceuticals Corporation
- Distributor
- Nationwide in the U.S.A.
- Lot
- Lot #: 21041W, Exp. 8/31/2022; 21081W, Exp. 11/30/2022; 21102W, Exp. 2/28/2023
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.